Induced pluripotent stem cells (iPSCs) can self-renew indefinitely in culture and differentiate
into all specialized cell types including gametes. iPSCs do not exist naturally and are …

Islet transplantation is a highly effective treatment for select patients with type 1 diabetes.
Unfortunately, current use is limited to those with brittle disease due to donor limitations and …

Abstract In 2006, Shinya Yamanaka generated induced pluripotent stem cells (iPSCs),
which has been the major scientific event of the decade that caught the eye of many …

Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to
consider the various ethical, legal, and social issues engaged by this fast-moving field. Here …

Few areas of recent research have received as much focus or generated as much
excitement and debate as stem cell research. Hope for the therapeutic promise of this field …

Human embryonic stem cells (hESCs), owing to their potential promise to develop into any
somatic cell type, have radicalized biotechnology research and application in clinical …

The field of induced pluripotent stem cells (iPSCs) will be subject to a wide range of laws
and research ethics policies, many of which exist as a result of the controversies associated …

Background The increased use of human biological material for cell-based research and
clinical interventions poses risks to the privacy of patients and donors, including the …

We conducted a study to review the consenting process in a vaginal Microbicide feasibility
study conducted in Mazabuka, Zambia. Participants were drawn from those participating in …

This article is a consensus statement by an international interdisciplinary group of academic
experts and Canadian policy-makers on emerging ethical, legal, and social issues in human …